MedPath

To know the effectiveness of different origin bone graft material in earlier formation of bone in bone defects after removal of disease.

Recruiting
Conditions
Patients who requires bone grafting after cystectomy or apicoectony .
Registration Number
CTRI/2014/09/004947
Lead Sponsor
DrVivekanand Kattimani
Brief Summary

Egg shell derived hydroxyapatite showed biocompatibility , better bone healing compared to bovine derived hydroxyapatite. Raw material for Egg shell derived hydroxyapatite is available in unlimited quantity. It can be easily sterilized by autoclaving without altering its biological properties. It’s economical and showed good bone regeneration efficacy in rats and surface modified egg shell material in human maxillary defects. .

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients with periapical cyst diagnosed clinically and radiologically,who required cystectomy and grafting .

Exclusion Criteria
  • Medically compromised patients.
  • Patients with metabolic diseases e.g.diabetes.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Enhanced bone healing4-8 weeks
Secondary Outcome Measures
NameTimeMethod
Good bone density, early bone formation, less pain. No infection4-8 weeks

Trial Locations

Locations (1)

Department of Oral and Maxillofacial surgery

🇮🇳

Guntur, ANDHRA PRADESH, India

Department of Oral and Maxillofacial surgery
🇮🇳Guntur, ANDHRA PRADESH, India
Dr vivekanand kattimani
Principal investigator
09912400988
drvivekanandsk@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.